Search by Drug Name or NDC
NDC 35573-0414-02 Methocarbamol 750 mg/1 Details
Methocarbamol 750 mg/1
Methocarbamol is a ORAL TABLET, COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Burel Pharmaceuticals, Inc.. The primary component is METHOCARBAMOL.
MedlinePlus Drug Summary
Methocarbamol is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Methocarbamol is in a class of medications called muscle relaxants. It works by slowing activity in the nervous system to allow the body to relax
Related Packages: 35573-0414-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Methocarbamol
Product Information
| NDC | 35573-0414 |
|---|---|
| Product ID | 35573-414_f4033ddd-4af5-812e-e053-2a95a90a2d17 |
| Associated GPIs | 75100070000310 |
| GCN Sequence Number | 004655 |
| GCN Sequence Number Description | methocarbamol TABLET 750 MG ORAL |
| HIC3 | H6H |
| HIC3 Description | SKELETAL MUSCLE RELAXANTS |
| GCN | 17893 |
| HICL Sequence Number | 001938 |
| HICL Sequence Number Description | METHOCARBAMOL |
| Brand/Generic | Generic |
| Proprietary Name | Methocarbamol |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Methocarbamol |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, COATED |
| Route | ORAL |
| Active Ingredient Strength | 750 |
| Active Ingredient Units | mg/1 |
| Substance Name | METHOCARBAMOL |
| Labeler Name | Burel Pharmaceuticals, Inc. |
| Pharmaceutical Class | Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209312 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 35573-0414-02 (35573041402)
| NDC Package Code | 35573-414-02 |
|---|---|
| Billing NDC | 35573041402 |
| Package | 100 TABLET, COATED in 1 BOTTLE (35573-414-02) |
| Marketing Start Date | 2019-09-30 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.04982 |
| Pricing Unit | EA |
| Effective Date | 2022-11-23 |
| NDC Description | METHOCARBAMOL 750 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis